Maze Therapeutics Ownership | Who Owns Maze Therapeutics?


OverviewRevenueFinancialsChart

Maze Therapeutics Ownership Summary


Maze Therapeutics is owned by 139.85% institutional investors, 11.49% insiders.

MAZE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMaze Therapeutics139.85%11.49%-51.34%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202567-40,037,113-139-67---

MAZE Ownership FAQ


Who Owns Maze Therapeutics?

Maze Therapeutics shareholders are primarily institutional investors at 139.85%, followed by 11.49% insiders and -51.34% retail investors. The average institutional ownership in Maze Therapeutics's industry, Biotech Stocks , is 63.84%, which Maze Therapeutics exceeds.

Does Blackrock own Maze Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Maze Therapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools